Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Join us at the leading European meeting in cardio‑oncology, held within the Cardio Oncology Congress 2026 in Vienna. On 19 June 2026, the European Society of Cardiology (ESC), through the ESC Council of Cardio‑Oncology, will host the second multi‑stakeholder meeting of the EU‑funded RESILIENCE project, supported by the European Commission. This event will bring together […]
